Results 121 to 130 of about 284,051 (203)

Statins for children with familial hypercholesterolemia

open access: yes, 2017
Background: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant disorder meaning heterozygotes, or carriers, are affected. Those who are homozygous have severe disease.
Vuorio, A.   +7 more
core   +1 more source

PCSK9 Inhibitors Reduce Oxidative Stress Biomarkers in Heterozygous Familial Hypercholesterolemia. [PDF]

open access: yesJ Cell Mol Med
Woźniak-Szczepocka A   +5 more
europepmc   +1 more source

CO18 | Relationship between gut permeability and PCSK9 in heterozygous familial hypercholesterolemia

open access: yesBleeding, Thrombosis and Vascular Biology
Background: Gut dysbiosis is a major determinant of low-grade endotoxaemia via dysfunction of the intestinal barrier scaffold, which is a prerequisite for Lipopolysaccharide (LPS) translocation into the systemic circulation.
doaj   +1 more source

Non-Responder to Inclisiran and Evolocumab-A Female Patient with Heterozygous Familial Hypercholesterolemia and Statin Intolerance. [PDF]

open access: yesDiseases
Muszyński P   +7 more
europepmc   +1 more source

Estimated Yield of Screening for Heterozygous Familial Hypercholesterolemia With and Without Genetic Testing in US Adults. [PDF]

open access: yesJ Am Heart Assoc, 2022
Bellows BK   +8 more
europepmc   +1 more source

Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia. [PDF]

open access: yesJ Atheroscler Thromb
Shishikura D   +8 more
europepmc   +1 more source

Triple Assessments of Atherosclerosis in Patients With Heterozygous Familial Hypercholesterolemia. [PDF]

open access: yesJACC Asia
Tada H   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy